Randomized Trial Standard of Care Vascular Access Strategies for (Neo)Adjuvant Trastuzumab-based Breast Cancer Treatment.

NCT02632435 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Cancer

Interventions

DEVICE: PICC
DEVICE: PORT

Sponsor

Ottawa Hospital Research Institute